Your browser doesn't support javascript.
loading
The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings.
Mallat, A; Teixeira-Clerc, F; Deveaux, V; Manin, S; Lotersztajn, S.
Affiliation
  • Mallat A; INSERM, U955, Créteil, France.
Br J Pharmacol ; 163(7): 1432-40, 2011 Aug.
Article in En | MEDLINE | ID: mdl-21457226
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptor, Cannabinoid, CB1 / Receptor, Cannabinoid, CB2 / Endocannabinoids / Cannabinoid Receptor Modulators / Liver Diseases Limits: Animals / Humans Language: En Journal: Br J Pharmacol Year: 2011 Document type: Article Affiliation country: Francia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptor, Cannabinoid, CB1 / Receptor, Cannabinoid, CB2 / Endocannabinoids / Cannabinoid Receptor Modulators / Liver Diseases Limits: Animals / Humans Language: En Journal: Br J Pharmacol Year: 2011 Document type: Article Affiliation country: Francia Country of publication: Reino Unido